Published June 29, 2023 | Version v1
Journal article Open

Metformin: A Reflection on My Journey as Antidiabetic Drug

Authors/Creators

  • 1. Former Professor, Department of Pharmacology, Gujarat Adani Institute of Medical Sciences and GK General Hospital, Bhuj, Kachchh, Gujarat-370001

Description

Here is a reflection by Metformin on its metaphoric journey and evolution as an antidiabetic drug and further role it presumes to play in alleviating human sufferings.

Files

9. EF Khilnani G.pdf

Files (317.9 kB)

Name Size
md5:615b0618922697bb3054c59eb3b3eae6
317.9 kB Preview Download

Additional details

References

  • Baily CJ. Metformin: historical overview. Diabetologia. 2017;60(9):1566-1576. doi: 10.1007/s00125-017-4318-z.
  • Nattrass M, Alberti KGMM. Biguanides. Diabetologia. 1978;14(2):71-4. doi: 10.1007/BF01263443
  • Sterne J. Du nouveau dans les antidiabétiques. La NN dimethylamine guanyl guanidine (N.N.D.G.). Maroc Med 1957;36:1295–1296.
  • Group UKPDS. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet 1998;352(9131):854–65. https://doi.org/10.1016/S0140-6736(98)07037-8.
  • WHO Model Lists of Essential Medicines. Available from: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists. Accessed on: 15.06.2023
  • Gong Li, Goswami S, Giacomini KM, Altmana RB, and Kleina TE. Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2012; 22(11): 820–827.
  • Buxton ILO: Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism,and Elimination. Ch 2 Goodman and Gilman's The Pharmacological Basis of Therapeutics. Eds BruntonLL, Knollmann BC: 14th Ed, 2023, McGrawHill Publishers, NewYork, PP 23-42
  • Dujic T, Zhou K, Yee S et al: Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A MetGen Meta-Analysis. CLINICAL PHARMACOLOGY & THERAPEUTICS: 2017; 101 (6): 763-772
  • Zhou K, Donnelly LA, Kimber CH, Donnan PT, Doney AS, Leese G, et al. Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study. Diabetes. 2009; 58:1434–1439. [PubMed: 19336679]
  • Aslanian HR et al. AGA Clinical Practice Update on pancreas cancer screening in high-risk individuals: expert review. Gastroenterology. 2020;159:358. [PMID: 32416142]
  • Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia 2017;60:1586–1593.
  • Gangopadhyay KK, Singh P. Consensus statement on dose modifications of antidiabetic agents in patients with hepatic impairment. Indian J Endocr Metab 2017;21:341-54.
  • Wu H, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med, 2017, 23:850–858.
  • Triggle CR, Mohammed I, Bshesh K, Marei I, Ye K, Ding H, MacDonald R, Hollenberg MD, Hill MA. Metformin: Is it a drug for all reasons and diseases? Metabolism. 2022 Aug;133:155223. doi: 10.1016/j.metabol.2022.155223. Epub 2022 May 29. PMID: 35640743.
  • Wensink MJ, Lu Y, Tian L, Shaw GM, Rizzi S, Jensen TK, Mathiesen ER, Skakkebæk NE, Lindahl-Jacobsen R, Eisenberg ML. Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring : A Nationwide Cohort Study. Ann Intern Med. 2022 May;175(5):665-673. doi: 10.7326/M21-4389. Epub 2022 Mar 29. PMID: 35344380; PMCID: PMC9844982.
  • Koenig RJ, Bren GA Thyroid and Antithyroid Drugs. Ch 47: In Goodman and Gilman's The Pharmacological Basis of Therapeutics. Eds Brunton LL, Knollmann BC: 14th Ed, 2023, McGrawHill Publishers, New York, PP 943-957.
  • Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017 Sep;60(9):1577-1585. doi: 10.1007/s00125-017-4342-z. Epub 2017 Aug 3. PMID: 28776086; PMCID: PMC5552828.
  • Forslund K, Hildebrand F, Nielsen T et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 2015;528:262–266. https://doi.org/10.1038/nature15766
  • Griffin SJ, Leaver JK, Irving GJ. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia 2017;60:1620–1629. doi 10.1007/s00125-017-4337-9
  • Pollak M. The effects of metformin on gut microbiota and the immune system as research frontiers. Diabetologia. 2017 Sep;60(9):1662-1667. doi: 10.1007/s00125-017-4352-x. Epub 2017 Aug 2. PMID: 28770326.
  • Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008 May 8;358(19):2003-15. doi: 10.1056/NEJMoa0707193. Erratum in: N Engl J Med. 2008 Jul 3;359(1):106. PMID: 18463376.
  • Newman C, Dunne FP. Metformin for pregnancy and beyond: the pros and cons. Diabet Med. 2022 Mar;39(3):e14700. doi: 10.1111/dme.14700. Epub 2021 Oct 7. PMID: 34569082.
  • Brand KMG, Saarelainen L, Sonajalg J, et al. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. BMJ Open Diab Res Care 2022;10:e002363. doi:10.1136/ bmjdrc-2021-002363
  • Balsells M, García-Patterson A, Solà I, Roqué M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015 Jan 21;350:h102. doi: 10.1136/bmj.h102. PMID: 25609400; PMCID: PMC4301599.
  • Hostalek U, Campbell IW. Metformin for diabetes prevention: an update of the evidence base. Curr Med Res Opin. 2021;37(10): 1705–1717
  • Campbell IW. Metformin: a 60-year odyssey with the journey still continuing - a personal commentary from Professor Ian Campbell. Curr Med Res Opin. 2022 Jan;38(1):55-58. doi: 10.1080/03007995.2021.2003149. Epub 2021 Dec 3. PMID: 34738843.
  • Livingstone R, Boyle JG, Petrie JR; REMOVAL Study Team. A new perspective on metformin therapy in type 1 diabetes. Diabetologia. 2017 Sep;60(9):1594-1600. doi: 10.1007/s00125-017-4364-6. Epub 2017 Aug 2. PMID: 28770327; PMCID: PMC5552844.
  • Hanem LGE, Stridsklev S, Júlíusson PB, Salvesen Ø, Roelants M, Carlsen SM, Ødegård R, Vanky E. Metformin Use in PCOS Pregnancies Increases the Risk of Offspring Overweight at 4 Years of Age: Follow-Up of Two RCTs. J Clin Endocrinol Metab. 2018 Apr 1;103(4):1612-1621. doi: 10.1210/jc.2017-02419. PMID: 29490031.
  • Correll CU, Sikich L, Reeves G, Johnson J, Keeton C, Spanos M, Kapoor S, Bussell K, Miller L, Chandrasekhar T, Sheridan EM, Pirmohamed S, Reinblatt SP, Alderman C, Scheer A, Borner I, Bethea TC, Edwards S, Hamer RM, Riddle MA. Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial. World Psychiatry. 2020 Feb;19(1):69-80. doi: 10.1002/wps.20714. PMID: 31922663; PMCID: PMC6953545.
  • Friedman LS. Live, Biliary Tree and pancreas Disorders. Ch 16. Current Medical diagnosis and Treatment Eds Papadakis et al.: McGraw Hill, New Delhi, 2023
  • Bubna AK. Metformin - For the dermatologist. Indian J Pharmacol 2016;48:4-10
  • Anisimov VN. Metformin for cancer and aging prevention: is it a time to make the long story short? Oncotarget 2015;6(37):39398. https://doi.org/10.18632/oncotarget.6347
  • Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis. Ageing Res Rev 2017;40:31–44. https://doi.org/10.1016/j.arr.2017.08.003
  • Bannister CA, Holden S, Jenkins-Jones S, Morgan CL, Halcox J, Schernthaner G, et al. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes Metab 2014;16 (11):1165–73. https://doi.org/10.1111/dom.12354
  • Kulkarni AS, Brutsaert EF, Anghel V, Zhang K, Bloomgarden N, Pollak M, et al. Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults. Aging Cell 2018;17(2):e12723. https://doi.org/10.1111/acel.12723
  • Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a tool to target aging. Cell Metab 2016;23(6):1060–5. https://doi.org/10.1016/j. cmet.2016.05.011.
  • Justice JN, Niedernhofer L, Robbins PD, Aroda VR, Espeland MA, Kritchevsky SB, Kuchel GA, Barzilai N. Development of Clinical Trials to Extend Healthy Lifespan. Cardiovasc Endocrinol Metab. 2018 Dec;7(4):80-83. doi: 10.1097/XCE.0000000000000159. PMID: 30906924; PMCID: PMC6428447.